Ipilimumab-associated cholestatic hepatitis: a case report and literature review.
Sign Up to like & getrecommendations! Published in 2017 at "Melanoma research"
DOI: 10.1097/cmr.0000000000000366
Abstract: Ipilimumab is a monoclonal antibody that exerts its effects by inhibiting the cytotoxic T-lymphocyte-associated protein 4 receptor on cytotoxic T lymphocytes. It is frequently used for the treatment of unresectable or metastatic melanoma. Ipilimumab may… read more here.
Keywords: cholestatic hepatitis; hepatitis; case; associated cholestatic ... See more keywords